DE1470045A1 - alpha-Halogenmethylindolyl-(3)-essigsaeuren und Verfahren zu ihrer Herstellung - Google Patents

alpha-Halogenmethylindolyl-(3)-essigsaeuren und Verfahren zu ihrer Herstellung

Info

Publication number
DE1470045A1
DE1470045A1 DE19631470045 DE1470045A DE1470045A1 DE 1470045 A1 DE1470045 A1 DE 1470045A1 DE 19631470045 DE19631470045 DE 19631470045 DE 1470045 A DE1470045 A DE 1470045A DE 1470045 A1 DE1470045 A1 DE 1470045A1
Authority
DE
Germany
Prior art keywords
indolyl
methyl
substituted
chlorobenzyl
methoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19631470045
Other languages
German (de)
English (en)
Inventor
Sarett Lewis Hastings
Tsung-Ying Shen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of DE1470045A1 publication Critical patent/DE1470045A1/de
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/22Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an aralkyl radical attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DE19631470045 1962-09-07 1963-08-26 alpha-Halogenmethylindolyl-(3)-essigsaeuren und Verfahren zu ihrer Herstellung Pending DE1470045A1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US222179A US3259622A (en) 1962-09-07 1962-09-07 1-benzyl-3-indolyl-alpha-haloalkyl and alkylidenyl acetic acids
US45201865A 1965-04-29 1965-04-29
US452010A US3388127A (en) 1962-09-07 1965-04-29 Alpha-halomethyl-1-pyrazine carbonyl-3-indolylacetic acids
US452015A US3399198A (en) 1962-09-07 1965-04-29 1-pyrimidinoyl-and 1-imidazoloyl-3-haloacetyl indoles
US452022A US3326930A (en) 1962-09-07 1965-04-29 alpha-halomethyl-(1-oxazole-carbonylindol-3-yl) acetic acids and certain intermediates therefor

Publications (1)

Publication Number Publication Date
DE1470045A1 true DE1470045A1 (de) 1969-05-29

Family

ID=27539838

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19631470045 Pending DE1470045A1 (de) 1962-09-07 1963-08-26 alpha-Halogenmethylindolyl-(3)-essigsaeuren und Verfahren zu ihrer Herstellung

Country Status (10)

Country Link
US (5) US3259622A (en:Method)
AT (2) AT263765B (en:Method)
BE (2) BE637036A (en:Method)
CH (1) CH450416A (en:Method)
DE (1) DE1470045A1 (en:Method)
DK (1) DK120898B (en:Method)
FR (3) FR1535407A (en:Method)
GB (6) GB1063385A (en:Method)
NL (2) NL297644A (en:Method)
SE (1) SE309040B (en:Method)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3929820A (en) * 1967-09-26 1975-12-30 Bayer Ag Process for the production of N-tritylimidazoles
JPS5683472A (en) * 1979-12-12 1981-07-08 Teijin Ltd Preparation of 3-acyl-1-substituted indole derivative
US4499279A (en) * 1980-04-10 1985-02-12 Sandoz, Inc. Isoxazolyl indolamines
JPS57159738A (en) * 1981-03-30 1982-10-01 Sagami Chem Res Center 2-halomethylene-arylacetice acid derivative
US5238938A (en) * 1989-02-10 1993-08-24 Otsuka Pharmaceutical Co., Ltd. Indole derivatives
WO1990009380A1 (en) * 1989-02-10 1990-08-23 Otsuka Pharmaceutical Co., Ltd. Indole derivatives, preparation thereof, and drug for preventing and treating nephritis containing same
US5166170A (en) * 1989-07-03 1992-11-24 Hoechst-Roussel Pharmaceuticals Incorporated 2-(aminoaryl) indoles and indolines as topical antiinflammatory agents for the treatment of skin disorders
GB9004301D0 (en) * 1990-02-26 1990-04-18 Fujisawa Pharmaceutical Co Indolebutyric acid derivatives and process for preparation thereof
US5283251A (en) * 1990-02-26 1994-02-01 Fujisawa Pharmaceutical Co., Ltd. Indole derivatives
FR2658818B1 (fr) * 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5064851A (en) * 1990-07-24 1991-11-12 Pfizer Inc. 3-(1-substituted-pyrazoyl)-2-oxindole derivatives, compositions and use
JP2599665B2 (ja) * 1991-05-01 1997-04-09 大塚製薬株式会社 ピラジン誘導体
IL109311A0 (en) * 1993-04-16 1994-07-31 Lilly Co Eli 1H-indole-3-acetamide sPla2 inhibitors
MY112897A (en) * 1994-04-01 2001-10-31 Lilly Co Eli Ih-indole-3-glyoxylamide spla2 inhibitors
US6214876B1 (en) 1994-07-21 2001-04-10 Eli Lilly And Company Indene-1-acetamide sPLA2 inhibitors
US5641800A (en) * 1994-07-21 1997-06-24 Eli Lilly And Company 1H-indole-1-functional sPLA2 inhibitors
US5604253A (en) * 1995-05-22 1997-02-18 Merck Frosst Canada, Inc. N-benzylindol-3-yl propanoic acid derivatives as cyclooxygenase inhibitors
AU748403B2 (en) 1998-04-28 2002-06-06 Elbion Ag New hydroxyindoles, their use as phosphodiesterase 4 inhibitors and method for producing same
DE69923505T2 (de) 1998-08-17 2006-01-12 Givaudan S.A. Oximcarbonsäure Derivate
EP0980863B1 (en) * 1998-08-17 2005-02-02 Givaudan SA Oxime carboxylic acid derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB869775A (en) * 1958-09-24 1961-06-07 Upjohn Co 3-indolyl ketones
US2978459A (en) * 1959-08-05 1961-04-04 Upjohn Co Ketals of (3-indolyl)-aminoalkanones
US3201414A (en) * 1963-07-22 1965-08-17 Merck & Co Inc New 1-heteroacyl-3-indolyl aliphatic acids
AT290523B (de) * 1962-01-05 1971-06-11 Merck & Co Inc Verfahren zur Herstellung neuer α-(3-Indolyl)-carbonsäuren
US3242192A (en) * 1962-09-07 1966-03-22 Merck & Co Inc Alpha-haloalkyl (3-indolyl) acetic acid derivatives

Also Published As

Publication number Publication date
US3326930A (en) 1967-06-20
US3388127A (en) 1968-06-11
FR3555M (en:Method) 1965-10-22
FR1535407A (fr) 1968-08-09
GB1049840A (en) 1966-11-30
AT263765B (de) 1968-08-12
NL297644A (en:Method) 1965-11-10
BE637036A (en:Method) 1964-03-05
US3259622A (en) 1966-07-05
US3426038A (en) 1969-02-04
CH450416A (de) 1968-01-31
GB1048347A (en) 1966-11-16
BE637037A (en:Method) 1964-03-05
GB1063383A (en) 1967-03-30
NL297645A (en:Method) 1965-11-10
SE309040B (en:Method) 1969-03-10
DK120898B (da) 1971-08-02
GB1063385A (en) 1967-03-30
FR3556M (en:Method) 1965-10-22
AT262274B (de) 1968-06-10
GB1063384A (en) 1967-03-30
GB1048346A (en) 1966-11-16
US3399198A (en) 1968-08-27

Similar Documents

Publication Publication Date Title
DE1470045A1 (de) alpha-Halogenmethylindolyl-(3)-essigsaeuren und Verfahren zu ihrer Herstellung
DD280320A5 (de) Herstellung von zwischenprodukten der oxophthalazinyl-essigsaeuren mit benzothiazol oder anderen heterocyclischen seitenketten
DE2255167A1 (de) Alpha-oximinocarbonsaeurederivate
EP0380712B1 (de) Verfahren zur Herstellung von 2,6-Dichlordiphenylaminessigsäurederivaten
CH597199A5 (en) 3-Phenyl pyridaz-6-ones prodn.
EP0184981B1 (de) Neue Pyrrolinone und deren Zwischenprodukte
DE2624344C2 (de) Verfahren zur Herstellung von in 1-Stellung unsubstituierten 3-(2-Hydroxyäthyl)-indol-Derivaten
DE3217904A1 (de) Cyclopentenon-derivate und verfahren zu ihrer herstellung
DE2057840A1 (de) Verfahren zur Herstellung von Indolderivaten
CH450419A (de) Verfahren zur Herstellung von a-(3-Indolyl)-niederaliphatischen Estern bzw. Amiden
EP0025501B1 (de) Neue N-Aminoalkylindol-Derivate und ihre Salze; Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2409313A1 (de) Neue pyrrolyl-verbindungen und verfahren zu ihrer herstellung
DE1620015A1 (de) N-1-substituierte 3-Indolylsaeuren und Verfahren zu deren Herstellung
DE2804894A1 (de) Halogen-benzofuranon-carbonsaeuren
AT256095B (de) Verfahren zur Herstellung von neuen substituierten α-(3-Indolyl)-säureamiden
DE2439284A1 (de) Neue aminopyrrol-derivate
AT258281B (de) Verfahren zur Herstellung von neuen Indolylsäureamiden
CH644103A5 (de) In 1-stellung durch einen kohlenwasserstoffrest substituierte 5-cyano-pyrrolyl-essigsaeuren, ihre herstellung und verwendung zur herstellung entsprechender 5-acyl-verbindungen.
AT267518B (de) Verfahren zur Herstellung von neuen α-(3-Indolyl)-essigsäuren und ihren Salzen
DE2319280A1 (de) 1-substituierte pyrazolone-(5), verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
AT256099B (de) Verfahren zur Herstellung neuer α-(3-Indolyl)-carbonsäuren
AT266117B (de) Verfahren zur Herstellung von neuen aliphatischen α-(3-Indolyl)-carbonsäuren und ihren Salzen
DE2737195A1 (de) Benzolsulfonamidderivate und verfahren zu ihrer herstellung
DE2243667A1 (de) Neue organische verbindungen und verfahren zu deren herstellung
AT263764B (de) Verfahren zur Herstellung von neuen α-Halogenmethylenyl-3-indolylessigsäuren und von deren Salzen, Estern und Amiden